Literature DB >> 30995113

Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling.

Ling Hao1, Samuel Thomas2, Tyler Greer3, Chad M Vezina2,4,5, Sagar Bajpai6, Arya Ashok6, Angelo M De Marzo7, Charles J Bieberich6,8, Lingjun Li1,2,3, William A Ricke1,2,5,9.   

Abstract

Inflammation is involved in many prostate pathologies including infection, benign prostatic hyperplasia, and prostate cancer. Preclinical models are critical to our understanding of disease mechanisms, yet few models are genetically tractable. Here, we present a comparative quantitative proteomic analysis of urine from mice with and without prostate-specific inflammation induced by conditional prostate epithelial IL-1β expression. Relative quantification and sample multiplexing was achieved using custom 4-plex N,N-dimethyl leucine (DiLeu) isobaric tags and nanoflow ultrahigh-performance liquid chromatography coupled to high-resolution tandem mass spectrometry. Each set of 4-plex DiLeu reagents allows four urine samples to be analyzed simultaneously, providing high-throughput and accurate quantification of urinary proteins. Proteins involved in the acute phase response, including haptoglobin, inter-α-trypsin inhibitor, and α1-antitrypsin 1-1, were differentially represented in the urine of mice with prostate inflammation. Mass spectrometry-based quantitative urinary proteomics represents a promising bioanalytical strategy for biomarker discovery and the elucidation of molecular mechanisms in urological research.

Entities:  

Keywords:  benign prostatic hyperplasia; inflammation; interleukin-1β; lower urinary tract symptoms, mass spectrometry; urine proteomics

Mesh:

Substances:

Year:  2019        PMID: 30995113      PMCID: PMC6620594          DOI: 10.1152/ajprenal.00387.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  46 in total

Review 1.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  IgG gene expression and its possible significance in prostate cancers.

Authors:  Yuxuan Liu; Zhengshan Chen; Na Niu; Qing Chang; Ruishu Deng; Christine Korteweg; Jiang Gu
Journal:  Prostate       Date:  2011-08-30       Impact factor: 4.104

4.  N,N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics.

Authors:  Feng Xiang; Hui Ye; Ruibing Chen; Qiang Fu; Lingjun Li
Journal:  Anal Chem       Date:  2010-04-01       Impact factor: 6.986

Review 5.  The interactions between inflammation and coagulation.

Authors:  Charles T Esmon
Journal:  Br J Haematol       Date:  2005-11       Impact factor: 6.998

6.  Tumor immunobiological differences in prostate cancer between African-American and European-American men.

Authors:  Tiffany A Wallace; Robyn L Prueitt; Ming Yi; Tiffany M Howe; John W Gillespie; Harris G Yfantis; Robert M Stephens; Neil E Caporaso; Christopher A Loffredo; Stefan Ambs
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

7.  Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis.

Authors:  Ryan P McMullin; Laura N Mutton; Charles J Bieberich
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

8.  Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model.

Authors:  Yuan Yuan; Fanshuang Zhang; Jianqiang Wu; Chen Shao; Youhe Gao
Journal:  Sci Rep       Date:  2015-03-20       Impact factor: 4.379

9.  An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes.

Authors:  Lulu Jia; Ling Zhang; Chen Shao; Eli Song; Wei Sun; Mingxi Li; Youhe Gao
Journal:  PLoS One       Date:  2009-04-20       Impact factor: 3.240

10.  From hundreds to thousands: Widening the normal human Urinome (1).

Authors:  Laura Santucci; Giovanni Candiano; Andrea Petretto; Maurizio Bruschi; Chiara Lavarello; Elvira Inglese; Pier Giorgio Righetti; Gian Marco Ghiggeri
Journal:  J Proteomics       Date:  2014-08-12       Impact factor: 4.044

View more
  5 in total

1.  Spatiotemporal Proteomics Reveals the Molecular Consequences of Hormone Treatment in a Mouse Model of Lower Urinary Tract Dysfunction.

Authors:  Samuel Thomas; Ling Hao; Kellen DeLaney; Dalton McLean; Laura Steinke; Paul C Marker; Chad M Vezina; Lingjun Li; William A Ricke
Journal:  J Proteome Res       Date:  2020-03-16       Impact factor: 4.466

2.  Multiplexed quantitative neuropeptidomics via DiLeu isobaric tagging.

Authors:  Christopher S Sauer; Lingjun Li
Journal:  Methods Enzymol       Date:  2021-12-07       Impact factor: 1.682

3.  Urinary Metabolomic and Proteomic Analyses in a Mouse Model of Prostatic Inflammation.

Authors:  Pingli Wei; Ling Hao; Fengfei Ma; Qing Yu; Amanda Rae Buchberger; Sanghee Lee; Wade Bushman; Lingjun Li
Journal:  Urine (Amst)       Date:  2020-05-27

Review 4.  Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.

Authors:  Nelson T Peterson; Chad M Vezina
Journal:  Toxics       Date:  2022-02-16

5.  Prostate-Specific Deletion of Cdh1 Induces Murine Prostatic Inflammation and Bladder Overactivity.

Authors:  Laura E Pascal; Shinsuke Mizoguchi; Wei Chen; Lora H Rigatti; Taro Igarashi; Rajiv Dhir; Pradeep Tyagi; Zeyu Wu; Zhenyu Yang; William C de Groat; Donald B DeFranco; Naoki Yoshimura; Zhou Wang
Journal:  Endocrinology       Date:  2021-01-01       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.